PPA
AVXL icon

Parametric Portfolio Associates’s Anavex Life Sciences AVXL Stock Holding History

Parametric Portfolio Associates’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$188K Sell
15,293
-32,828
-68% -$404K ﹤0.01% 3458
2021
Q4 		$834K Buy
48,121
+7,407
+18% +$141K ﹤0.01% 2857
2021
Q3 		$731K Sell
40,714
-117,470
-74% -$2.34M ﹤0.01% 2935
2021
Q2 		$3.62M Buy
158,184
+126,195
+394% +$1.87M ﹤0.01% 2078
2021
Q1 		$478K Buy
+31,989
New +$349K ﹤0.01% 3516
2020
Q3 		– Sell
-12,634
Closed -$62K – 3927
2020
Q2 		$62K Buy
+12,634
New +$47.7K ﹤0.01% 3844
2018
Q3 		– Sell
-16,553
Closed -$43K – 3938
2018
Q2 		$43K Sell
16,553
-2,909
-15% -$8.13K ﹤0.01% 3858
2018
Q1 		$54K Buy
+19,462
New +$55K ﹤0.01% 3899

Other funds holding AVXL

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Parametric Portfolio Associates's AVXL Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Anavex Life Sciences (AVXL) stake by 68% in Q1 2022, selling an estimated $404K and leaving 15,293 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #3458.

Parametric Portfolio Associates first reported a position in AVXL in Q1 2018 and has held it in 8 quarters since. The position peaked at $3.62M in Q2 2021. 139 funds tracked by Wall St. Rank hold AVXL as of Q1 2022.

  • Parametric Portfolio Associates held 15,293 shares of Anavex Life Sciences worth $188K as of Q1 2022.
  • Parametric Portfolio Associates sold 32,828 Anavex Life Sciences shares in Q1 2022, an estimated $404K.
  • Anavex Life Sciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3458 holding.
  • Parametric Portfolio Associates first reported a position in Anavex Life Sciences in Q1 2018 and has held it in 8 quarters since.
  • Parametric Portfolio Associates's Anavex Life Sciences position peaked at $3.62M in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.